Reference:
1. Hossain I, Khan MH, Rahman MS, Mullick AR, Aktaruzzaman M. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in Bangladesh: A descriptive study. Journal of Medical Science and Clinical Research. 2020;8(04).
2. Macera M, De Angelis G, Sagnelli C, Coppola N, COVID V. Clinical presentation of COVID-19: case series and review of the literature. Int J Environ Res Public Health. 2020;17(14):5062.
3. Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: acute segmental pulmonary emboli associated with novel coronavirus infection. The American journal of emergency medicine. 2020;38(7):1544. e1-. e3.
4. Chowdhury PB, Hossain S, Biswas RK. A combination of COVID-19 and dengue fever in Bangladesh: Preparedness of Bangladesh. Journal of Global Health. 2020;10(2).
5. Dengue and severe dengue WHO | World Health Organization: WHO | World Health Organization; 2021 [cited 2021 10 july 2021]. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.
6. Gagnon S, Quigley N, Dutau H, Delage A, Fortin M. Approach to hemoptysis in the modern era. Can Respir J. 2017;2017.
7. Singh V, Mishra SC, Singh P, Pradeepa A. Dengue Infection Induced Diffuse Alveolar Hemorrhage. Journal of Case Reports. 2020;10(2):68-71.
8. Ittrich H, Bockhorn M, Klose H, Simon M. The diagnosis and treatment of hemoptysis. Deutsches Ärzteblatt International. 2017;114(21):371.
9. Shi F, Yu Q, Huang W, Tan C. 2019 novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: CT and clinical features. Korean journal of radiology. 2020;21(5):537.
10. Marchiori E, Hochhegger B, Zanetti G. Pulmonary manifestations of dengue. Jornal Brasileiro de Pneumologia. 2020;46.
11. Mohan K, Nasimuddin S, Sathyaseelan RD, Meenakshisundaram PR, Gnanadesikan S, Malaiyan J. A study on clinical profile and laboratory parameters of dengue fever patients in Chennai, Tamil Nadu, India.
12. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. Overview of immune response during SARS-CoV-2 infection: lessons from the past. Front Immunol. 2020;11:1949.
13. Du F, Liu B, Zhang S. COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness. J Thromb Thrombolysis. 2021;51(2):313-29.
14. Mazzeffi MA, Chow JH, Tanaka K. COVID-19 associated hypercoagulability: manifestations, mechanisms, and management. Shock (Augusta, Ga). 2021;55(4):465.